This study has evaluated the predictive value of the pre-operative neutrophil–lymphocyte ratio in relation to clinicopathological parameters of BC, such as age, histological subtype, tumour grade, pT stage, pN stage, LVI, tumour size, HER2/ER/PR, and menopausal status. This evidence concerns the gene ERBB2 and breast cancer.